<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39232147</PMID><DateCompleted><Year>2024</Year><Month>09</Month><Day>05</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>04</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1476-4687</ISSN><JournalIssue CitedMedium="Internet"><Volume>633</Volume><Issue>8028</Issue><PubDate><Year>2024</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Nature</Title><ISOAbbreviation>Nature</ISOAbbreviation></Journal><ArticleTitle>Immune system adaptation during gender-affirming testosterone treatment.</ArticleTitle><Pagination><StartPage>155</StartPage><EndPage>164</EndPage><MedlinePgn>155-164</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41586-024-07789-z</ELocationID><Abstract><AbstractText>Infectious, inflammatory and autoimmune conditions present differently in males and females. SARS-CoV-2 infection in naive males is associated with increased risk of death, whereas females are at increased risk of long COVID<sup>1</sup>, similar to observations in other infections<sup>2</sup>. Females respond more strongly to vaccines, and adverse reactions are more frequent<sup>3</sup>, like most autoimmune diseases<sup>4</sup>. Immunological sex differences stem from genetic, hormonal and behavioural factors<sup>5</sup> but their relative importance is only partially understood<sup>6-8</sup>. In individuals assigned female sex at birth and undergoing gender-affirming testosterone therapy (trans men), hormone concentrations change markedly but the immunological consequences are poorly understood. Here we performed longitudinal systems-level analyses in 23 trans men and found that testosterone modulates a cross-regulated axis between type-I interferon and tumour necrosis factor. This is mediated by functional attenuation of type-I interferon responses in both plasmacytoid dendritic cells and monocytes. Conversely, testosterone potentiates monocyte responses leading to increased tumour necrosis factor, interleukin-6 and interleukin-15 production and downstream activation of nuclear factor kappa B-regulated genes and potentiation of interferon-&#x3b3; responses, primarily in natural killer cells. These findings in trans men are corroborated by sex-divergent responses in public datasets and illustrate the dynamic regulation of human immunity by sex hormones, with implications for the health of individuals undergoing hormone therapy and our understanding of sex-divergent immune responses in cisgender individuals.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Lakshmikanth</LastName><ForeName>Tadepally</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0001-7256-5770</Identifier><AffiliationInfo><Affiliation>Department of Women's and Children's Health, Karolinska Institutet, Solna, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Consiglio</LastName><ForeName>Camila</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-8901-2328</Identifier><AffiliationInfo><Affiliation>Department of Women's and Children's Health, Karolinska Institutet, Solna, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Laboratory Medicine, Lund University, Lund, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sardh</LastName><ForeName>Fabian</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Center for Molecular Medicine, Department of Medicine, Karolinska Institutet, Solna, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Science for Life Laboratory, Department of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Forlin</LastName><ForeName>Rikard</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Women's and Children's Health, Karolinska Institutet, Solna, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Jun</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Women's and Children's Health, Karolinska Institutet, Solna, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tan</LastName><ForeName>Ziyang</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Women's and Children's Health, Karolinska Institutet, Solna, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barcenilla</LastName><ForeName>Hugo</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0002-7255-362X</Identifier><AffiliationInfo><Affiliation>Department of Women's and Children's Health, Karolinska Institutet, Solna, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rodriguez</LastName><ForeName>Lucie</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-3692-9060</Identifier><AffiliationInfo><Affiliation>Department of Women's and Children's Health, Karolinska Institutet, Solna, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sugrue</LastName><ForeName>Jamie</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Translational Immunology Unit, Institut Pasteur, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Noori</LastName><ForeName>Peri</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Center for Molecular Medicine, Department of Medicine, Karolinska Institutet, Solna, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ivanchenko</LastName><ForeName>Margarita</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Women's and Children's Health, Karolinska Institutet, Solna, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pi&#xf1;ero P&#xe1;ez</LastName><ForeName>Laura</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Women's and Children's Health, Karolinska Institutet, Solna, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gonzalez</LastName><ForeName>Laura</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Women's and Children's Health, Karolinska Institutet, Solna, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Habimana Mugabo</LastName><ForeName>Constantin</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Women's and Children's Health, Karolinska Institutet, Solna, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Johnsson</LastName><ForeName>Anette</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Women's and Children's Health, Karolinska Institutet, Solna, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ryberg</LastName><ForeName>Henrik</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Clinical Chemistry, Sahlgrenska University Hospital, Gothenburg, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine and Clinical Nutrition, University of Gothenburg, Gothenburg, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hallgren</LastName><ForeName>&#xc5;sa</ForeName><Initials>&#xc5;</Initials><AffiliationInfo><Affiliation>Center for Molecular Medicine, Department of Medicine, Karolinska Institutet, Solna, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pou</LastName><ForeName>Christian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Women's and Children's Health, Karolinska Institutet, Solna, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Yang</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Women's and Children's Health, Karolinska Institutet, Solna, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mike&#x161;</LastName><ForeName>Jarom&#xed;r</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-9941-7855</Identifier><AffiliationInfo><Affiliation>Department of Women's and Children's Health, Karolinska Institutet, Solna, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>James</LastName><ForeName>Anna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Women's and Children's Health, Karolinska Institutet, Solna, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dahlqvist</LastName><ForeName>Per</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0002-6471-9503</Identifier><AffiliationInfo><Affiliation>Department of Public Health and Clinical Medicine, Ume&#xe5; University, Ume&#xe5;, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wahlberg</LastName><ForeName>Jeanette</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0003-4061-6830</Identifier><AffiliationInfo><Affiliation>Department of Medicine, &#xd6;rebro University, &#xd6;rebro, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hagelin</LastName><ForeName>Anders</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>ANOVA, Karolinska University Hospital, Stockholm, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, Karolinska Institutet, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Holmberg</LastName><ForeName>Mats</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-2884-9981</Identifier><AffiliationInfo><Affiliation>ANOVA, Karolinska University Hospital, Stockholm, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, Karolinska Institutet, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Degerblad</LastName><ForeName>Marie</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>ANOVA, Karolinska University Hospital, Stockholm, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Molecular Medicine and Surgery, Karolinska Institutet, Solna, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Isaksson</LastName><ForeName>Magnus</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Medical Sciences, Uppsala University, Uppsala, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Duffy</LastName><ForeName>Darragh</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-8875-2308</Identifier><AffiliationInfo><Affiliation>Translational Immunology Unit, Institut Pasteur, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>K&#xe4;mpe</LastName><ForeName>Olle</ForeName><Initials>O</Initials><Identifier Source="ORCID">0000-0001-6091-9914</Identifier><AffiliationInfo><Affiliation>Center for Molecular Medicine, Department of Medicine, Karolinska Institutet, Solna, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Endocrinology, Metabolism and Diabetes, Karolinska University Hospital, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Landegren</LastName><ForeName>Nils</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Center for Molecular Medicine, Department of Medicine, Karolinska Institutet, Solna, Sweden. nils.landegren@imbim.uu.se.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Science for Life Laboratory, Department of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden. nils.landegren@imbim.uu.se.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Brodin</LastName><ForeName>Petter</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0002-8103-0046</Identifier><AffiliationInfo><Affiliation>Department of Women's and Children's Health, Karolinska Institutet, Solna, Sweden. petter.brodin@ki.se.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medical Research Council, Laboratory of Medical Sciences, London, UK. petter.brodin@ki.se.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Immunology and Inflammation, Imperial College London, London, UK. petter.brodin@ki.se.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nature</MedlineTA><NlmUniqueID>0410462</NlmUniqueID><ISSNLinking>0028-0836</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C569274">IL15 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C508600">IL6 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007370">Interferon Type I</NameOfSubstance></Chemical><Chemical><RegistryNumber>82115-62-6</RegistryNumber><NameOfSubstance UI="D007371">Interferon-gamma</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D019409">Interleukin-15</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016328">NF-kappa B</NameOfSubstance></Chemical><Chemical><RegistryNumber>3XMK78S47O</RegistryNumber><NameOfSubstance UI="D013739">Testosterone</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014409">Tumor Necrosis Factor-alpha</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="ErratumIn"><RefSource>Nature. 2024 Oct;634(8033):E5. doi: 10.1038/s41586-024-08081-w</RefSource><PMID Version="1">39317781</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D066264" MajorTopicYN="N">Datasets as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003713" MajorTopicYN="N">Dendritic Cells</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007107" MajorTopicYN="N">Immune System</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007370" MajorTopicYN="N">Interferon Type I</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007371" MajorTopicYN="N">Interferon-gamma</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019409" MajorTopicYN="N">Interleukin-15</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007694" MajorTopicYN="N">Killer Cells, Natural</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009000" MajorTopicYN="N">Monocytes</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016328" MajorTopicYN="N">NF-kappa B</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012727" MajorTopicYN="N">Sex Characteristics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013739" MajorTopicYN="Y">Testosterone</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D063106" MajorTopicYN="Y">Transgender Persons</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014409" MajorTopicYN="N">Tumor Necrosis Factor-alpha</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>P.B., T.L. and J.M. are cofounders of Cytodelics AB (Stockholm, Sweden), which produces and distributes the whole blood cell stabilizer solutions used in this study. P.B. is an executive board member of Kancera AB, scientific advisor for Pixelgen Technologies AB, Helaina Inc., Scailyte AG, Oxford Immune Algorithmics Ltd, Sention Health AB and the Swedish Olympic Committee. The other authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>4</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>7</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>5</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>5</Day><Hour>0</Hour><Minute>50</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>4</Day><Hour>23</Hour><Minute>38</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>4</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39232147</ArticleId><ArticleId IdType="pmc">PMC11374716</ArticleId><ArticleId IdType="doi">10.1038/s41586-024-07789-z</ArticleId><ArticleId IdType="pii">10.1038/s41586-024-07789-z</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Brodin, P. Immune determinants of COVID-19 disease presentation and severity. Nat. Med.27, 28&#x2013;33 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33442016</ArticleId></ArticleIdList></Reference><Reference><Citation>Choutka, J., Jansari, V., Hornig, M. &amp; Iwasaki, A. Unexplained post-acute infection syndromes. Nat. Med.28, 911&#x2013;923 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35585196</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein, S. L., Marriott, I. &amp; Fish, E. N. Sex-based differences in immune function and responses to vaccination. Trans. R. Soc. Trop. Med. Hyg.109, 9&#x2013;15 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4447843</ArticleId><ArticleId IdType="pubmed">25573105</ArticleId></ArticleIdList></Reference><Reference><Citation>Cooper, G. S. &amp; Stroehla, B. C. The epidemiology of autoimmune diseases. Autoimmun. Rev.2, 119&#x2013;125 (2003).</Citation><ArticleIdList><ArticleId IdType="pubmed">12848952</ArticleId></ArticleIdList></Reference><Reference><Citation>Brodin, P. et al. Studying severe long COVID to understand post-infectious disorders beyond COVID-19. Nat. Med.28, 879&#x2013;882 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35383311</ArticleId></ArticleIdList></Reference><Reference><Citation>Piasecka, B. et al. Distinctive roles of age, sex, and genetics in shaping transcriptional variation of human immune responses to microbial challenges. Proc. Natl Acad. Sci. USA115, E488&#x2013;E497 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5776984</ArticleId><ArticleId IdType="pubmed">29282317</ArticleId></ArticleIdList></Reference><Reference><Citation>Brodin, P. et al. Variation in the human immune system is largely driven by non-heritable influences. Cell160, 37&#x2013;47 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4302727</ArticleId><ArticleId IdType="pubmed">25594173</ArticleId></ArticleIdList></Reference><Reference><Citation>Blanton, LV. et al. Stable and robust Xi and Y transcriptomes drive cell-type-specific autosomal and Xa responses in vivo and in vitro in four human cell types. Cell. Genom.&#xa0;4, 100628 (2024).</Citation><ArticleIdList><ArticleId IdType="pubmed">39111319</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang, H. et al. A distinct subset of plasmacytoid dendritic cells induces activation and differentiation of B and T lymphocytes. Proc. Natl Acad. Sci. USA114, 1988&#x2013;1993 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5338447</ArticleId><ArticleId IdType="pubmed">28167780</ArticleId></ArticleIdList></Reference><Reference><Citation>Villani, A.-C. et al. Single-cell RNA-seq reveals new types of human blood dendritic cells, monocytes, and progenitors. Science356, eaah4573 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5775029</ArticleId><ArticleId IdType="pubmed">28428369</ArticleId></ArticleIdList></Reference><Reference><Citation>Sulczewski, F. B. et al. Transitional dendritic cells are distinct from conventional DC2 precursors and mediate proinflammatory antiviral responses. Nat. Immunol.24, 1265&#x2013;1280 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10683792</ArticleId><ArticleId IdType="pubmed">37414907</ArticleId></ArticleIdList></Reference><Reference><Citation>See, P. et al. Mapping the human DC lineage through the integration of high-dimensional techniques. Science356, eaag3009 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7611082</ArticleId><ArticleId IdType="pubmed">28473638</ArticleId></ArticleIdList></Reference><Reference><Citation>Webb, K. et al. Sex and pubertal differences in the type 1 interferon pathway associate with both X chromosome number and serum sex hormone concentration. Front. Immunol.9, 3167 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6345344</ArticleId><ArticleId IdType="pubmed">30705679</ArticleId></ArticleIdList></Reference><Reference><Citation>Gr&#xfc;nhagel, B. et al. Reduction of IFN-I responses by plasmacytoid dendritic cells in a longitudinal trans men cohort. iScience26, 108209 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10637924</ArticleId><ArticleId IdType="pubmed">37953956</ArticleId></ArticleIdList></Reference><Reference><Citation>Honda, K. et al. IRF-7 is the master regulator of type-I interferon-dependent immune responses. Nature434, 772&#x2013;777 (2005).</Citation><ArticleIdList><ArticleId IdType="pubmed">15800576</ArticleId></ArticleIdList></Reference><Reference><Citation>Ciancanelli, M. J. et al. Life-threatening influenza and impaired interferon amplification in human IRF7 deficiency. Science348, 448&#x2013;453 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4431581</ArticleId><ArticleId IdType="pubmed">25814066</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang, Q. et al. Inborn errors of type I IFN immunity in patients with life-threatening COVID-19. Science370, eabd4570 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7857407</ArticleId><ArticleId IdType="pubmed">32972995</ArticleId></ArticleIdList></Reference><Reference><Citation>Pauli, E.-K. et al. Influenza A virus inhibits type I IFN signaling via NF-&#x3ba;B-dependent induction of SOCS-3 expression. PLoS Pathog.4, e1000196 (2008).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2572141</ArticleId><ArticleId IdType="pubmed">18989459</ArticleId></ArticleIdList></Reference><Reference><Citation>Simmons, D. P. et al. SLAMF7 engagement superactivates macrophages in acute and chronic inflammation. Sci. Immunol.7, eabf2846 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8991457</ArticleId><ArticleId IdType="pubmed">35148199</ArticleId></ArticleIdList></Reference><Reference><Citation>Uppal, S. S., Verma, S. &amp; Dhot, P. S. Normal values of CD4 and CD8 lymphocyte subsets in healthy Indian adults and the effects of sex, age, ethnicity, and smoking. Cytometry B Clin. Cytom.52B, 32&#x2013;36 (2003).</Citation><ArticleIdList><ArticleId IdType="pubmed">12599179</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee, B. et al. Age&#x2010; and sex&#x2010;related changes in lymphocyte subpopulations of healthy Asian subjects: from birth to adulthood. Cytometry26, 8&#x2013;15 (1996).</Citation><ArticleIdList><ArticleId IdType="pubmed">8809475</ArticleId></ArticleIdList></Reference><Reference><Citation>Halnan, E. T., Marshall, F. H. A. &amp; Yule, G. U. On the relation between the thymus and the generative organs and the influence of these organs upon growth. Proc. R. Soc. B88, 68&#x2013;86 (1914).</Citation></Reference><Reference><Citation>Dumont-Lagac&#xe9;, M., St-Pierre, C. &amp; Perreault, C. Sex hormones have pervasive effects on thymic epithelial cells. Sci. Rep.5, 12895 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4528223</ArticleId><ArticleId IdType="pubmed">26250469</ArticleId></ArticleIdList></Reference><Reference><Citation>Olsen, N. J. &amp; Kovacs, W. J. Evidence that androgens modulate human thymic T cell output. J. Invest. Med.59, 32 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3077079</ArticleId><ArticleId IdType="pubmed">21218609</ArticleId></ArticleIdList></Reference><Reference><Citation>Olsen, N. J., Olson, G., Viselli, S. M., Gu, X. &amp; Kovacs, W. J. Androgen receptors in thymic epithelium modulate thymus size and thymocyte development. Endocrinology142, 1278&#x2013;1283 (2001).</Citation><ArticleIdList><ArticleId IdType="pubmed">11181545</ArticleId></ArticleIdList></Reference><Reference><Citation>Afshan, G., Afzal, N. &amp; Qureshi, S. CD4+CD25(hi) regulatory T cells in healthy males and females mediate gender difference in the prevalence of autoimmune diseases. Clin. Lab.58, 567&#x2013;571 (2012).</Citation><ArticleIdList><ArticleId IdType="pubmed">22783590</ArticleId></ArticleIdList></Reference><Reference><Citation>Kissick, H. T. et al. Androgens alter T-cell immunity by inhibiting T-helper 1 differentiation. Proc. Natl Acad. Sci. USA111, 9887&#x2013;9892 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4103356</ArticleId><ArticleId IdType="pubmed">24958858</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwon, H. et al. Androgen conspires with the CD8+ T cell exhaustion program and contributes to sex bias in cancer. Sci. Immunol.7, eabq2630 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9374385</ArticleId><ArticleId IdType="pubmed">35420889</ArticleId></ArticleIdList></Reference><Reference><Citation>Guan, X. et al. Androgen receptor activity in T cells limits checkpoint blockade efficacy. Nature606, 791&#x2013;796 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10294141</ArticleId><ArticleId IdType="pubmed">35322234</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang, C. et al. Androgen receptor-mediated CD8+ T cell stemness programs drive sex differences in antitumor immunity. Immunity55, 1747 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">36103859</ArticleId></ArticleIdList></Reference><Reference><Citation>Shan, Q. et al. The transcription factor Runx3 guards cytotoxic CD8+ effector T cells against deviation towards follicular helper T cell lineage. Nat. Immunol.18, 931&#x2013;939 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5564218</ArticleId><ArticleId IdType="pubmed">28604718</ArticleId></ArticleIdList></Reference><Reference><Citation>Oh, H. &amp; Ghosh, S. NF&#x2010;&#x3ba;B: roles and regulation in different CD4+ T&#x2010;cell subsets. Immunol. Rev.252, 41&#x2013;51 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3576882</ArticleId><ArticleId IdType="pubmed">23405894</ArticleId></ArticleIdList></Reference><Reference><Citation>Consortium, et al. A blood atlas of COVID-19 defines hallmarks of disease severity and specificity. Cell185, 916&#x2013;938.e58 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8776501</ArticleId><ArticleId IdType="pubmed">35216673</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao, X.-N. et al. Single-cell immune profiling reveals distinct immune response in asymptomatic COVID-19 patients. Signal Transduct. Target. Ther.6, 342 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8443960</ArticleId><ArticleId IdType="pubmed">34531370</ArticleId></ArticleIdList></Reference><Reference><Citation>Oelen, R. et al. Single-cell RNA-sequencing of peripheral blood mononuclear cells reveals widespread, context-specific gene expression regulation upon pathogenic exposure. Nat. Commun.13, 3267 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9174272</ArticleId><ArticleId IdType="pubmed">35672358</ArticleId></ArticleIdList></Reference><Reference><Citation>Hertz, D. &amp; Schneider, B. Sex differences in tuberculosis. Semin. Immunopathol.41, 225&#x2013;237 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">30361803</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellott, D. W. et al. Mammalian Y chromosomes retain widely expressed dosage-sensitive regulators. Nature508, 494&#x2013;499 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4139287</ArticleId><ArticleId IdType="pubmed">24759411</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown, G. J. et al. TLR7 gain-of-function genetic variation causes human lupus. Nature605, 349&#x2013;356 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9095492</ArticleId><ArticleId IdType="pubmed">35477763</ArticleId></ArticleIdList></Reference><Reference><Citation>Palucka, A. K., Blanck, J.-P., Bennett, L., Pascual, V. &amp; Banchereau, J. Cross-regulation of TNF and IFN-&#x3b1; in autoimmune diseases. Proc. Natl Acad. Sci. USA102, 3372&#x2013;3377 (2005).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC552921</ArticleId><ArticleId IdType="pubmed">15728381</ArticleId></ArticleIdList></Reference><Reference><Citation>Rothuizen, L. E. et al. Influence of interferon &#x3b2;-1a dose frequency on PBMC cytokine secretion and biological effect markers. J. Neuroimmunol.99, 131&#x2013;141 (1999).</Citation><ArticleIdList><ArticleId IdType="pubmed">10496186</ArticleId></ArticleIdList></Reference><Reference><Citation>Cantaert, T., Baeten, D., Tak, P. P. &amp; van Baarsen, L. G. Type I IFN and TNF&#x3b1; cross-regulation in immune-mediated inflammatory disease: basic concepts and clinical relevance. Arthritis Res. Ther.12, 219 (2010).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2991015</ArticleId><ArticleId IdType="pubmed">21062511</ArticleId></ArticleIdList></Reference><Reference><Citation>Feldmann, M. &amp; Maini, R. N. Anti-TNF&#x3b1; therapy of rheumatoid arthritis: what have we learned? Immunology19, 163&#x2013;196 (2001).</Citation><ArticleIdList><ArticleId IdType="pubmed">11244034</ArticleId></ArticleIdList></Reference><Reference><Citation>Takayanagi, H. et al. RANKL maintains bone homeostasis through c-Fos-dependent induction of interferon-beta. Nature416, 744&#x2013;749 (2002).</Citation><ArticleIdList><ArticleId IdType="pubmed">11961557</ArticleId></ArticleIdList></Reference><Reference><Citation>Seillet, C. et al. The TLR-mediated response of plasmacytoid dendritic cells is positively regulated by estradiol in vivo through cell-intrinsic estrogen receptor &#x3b1; signaling. Blood119, 454&#x2013;464 (2012).</Citation><ArticleIdList><ArticleId IdType="pubmed">22096248</ArticleId></ArticleIdList></Reference><Reference><Citation>Griesbeck, M. et al. Sex differences in plasmacytoid dendritic cell levels of IRF5 drive higher IFN-&#x3b1; production in women. J. Immunol.195, 5327&#x2013;5336 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4654231</ArticleId><ArticleId IdType="pubmed">26519527</ArticleId></ArticleIdList></Reference><Reference><Citation>Zandman-Goddard, G., Solomon, M., Barzilai, A. &amp; Shoenfeld, Y. Lupus erythematosus tumidus induced by sex reassignment surgery. J. Rheumatol.34, 1938&#x2013;1940 (2007).</Citation><ArticleIdList><ArticleId IdType="pubmed">17696264</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao, L., Gu, Y. &amp; Yin, X. High serum tumor necrosis factor-alpha levels in women with polycystic ovary syndrome: a meta-analysis. PLoS ONE11, e0164021 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5072730</ArticleId><ArticleId IdType="pubmed">27764100</ArticleId></ArticleIdList></Reference><Reference><Citation>de Medeiros, S. F., Yamamoto, M. M. W., de Medeiros, M. A. S., Yamamoto, A. K. L. W. &amp; Barbosa, B. B. Polycystic ovary syndrome and risks for COVID-19 infection: a comprehensive review. Rev. Endocr. Metab. Disord.23, 251&#x2013;264 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8881900</ArticleId><ArticleId IdType="pubmed">35218458</ArticleId></ArticleIdList></Reference><Reference><Citation>Durcan, E. et al. TransCOVID: does gender-affirming hormone therapy play a role in contracting COVID-19? J. Sex Marital Ther.48, 415&#x2013;426 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">34806552</ArticleId></ArticleIdList></Reference><Reference><Citation>Beyer, M. et al. Tumor-necrosis factor impairs CD4+ T cell&#x2013;mediated immunological control in chronic viral infection. Nat. Immunol.17, 593&#x2013;603 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">26950238</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellofiore, N., Rana, S., Dickinson, H., Temple-Smith, P. &amp; Evans, J. Characterization of human-like menstruation in the spiny mouse: comparative studies with the human and induced mouse model. Hum. Reprod.33, 1715&#x2013;1726 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">30032205</ArticleId></ArticleIdList></Reference><Reference><Citation>Stearns, S. C. The Evolution of Life Histories (Oxford Univ. Press, 1992).</Citation></Reference><Reference><Citation>Muehlenbein, M. P. &amp; Bribiescas, R. G. Testosterone-mediated immune functions and male life histories. Am. J. Hum. Biol.17, 527&#x2013;558 (2005).</Citation><ArticleIdList><ArticleId IdType="pubmed">16136532</ArticleId></ArticleIdList></Reference><Reference><Citation>Metcalf, C. J. E. &amp; Graham, A. L. Schedule and magnitude of reproductive investment under immune trade-offs explains sex differences in immunity. Nat. Commun.9, 4391 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6197210</ArticleId><ArticleId IdType="pubmed">30348963</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitchell, E., Graham, A. L., &#xda;beda, F. &amp; Wild, G. On maternity and the stronger immune response in women. Nat. Commun.13, 4858 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9386672</ArticleId><ArticleId IdType="pubmed">35982048</ArticleId></ArticleIdList></Reference><Reference><Citation>Warren, G. L. et al. Physiological role of tumor necrosis factor &#x3b1; in traumatic muscle injury. FASEB J.16, 1630&#x2013;1632 (2002).</Citation><ArticleIdList><ArticleId IdType="pubmed">12207010</ArticleId></ArticleIdList></Reference><Reference><Citation>Romanowska-Pr&#xf3;chnicka, K. et al. The role of TNF-&#x3b1; and anti-TNF-&#x3b1; agents during preconception, pregnancy, and breastfeeding. Int. J. Mol. Sci.22, 2922 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7998738</ArticleId><ArticleId IdType="pubmed">33805757</ArticleId></ArticleIdList></Reference><Reference><Citation>Babbage, S. J. et al. Cytokine promoter gene polymorphisms and idiopathic recurrent pregnancy loss. J. Reprod. Immunol.51, 21&#x2013;27 (2001).</Citation><ArticleIdList><ArticleId IdType="pubmed">11438378</ArticleId></ArticleIdList></Reference><Reference><Citation>Anim-Nyame, N., Gamble, J., Sooranna, S. R., Johnson, M. R. &amp; Steer, P. J. Microvascular permeability is related to circulating levels of tumour necrosis factor-&#x3b1; in pre-eclampsia. Cardiovasc. Res.58, 162&#x2013;169 (2003).</Citation><ArticleIdList><ArticleId IdType="pubmed">12667958</ArticleId></ArticleIdList></Reference><Reference><Citation>Covert, L. T. et al. Effect of type I interferon on engineered pediatric skeletal muscle: a promising model for juvenile dermatomyositis. Rheumatology63, 209&#x2013;217 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10765138</ArticleId><ArticleId IdType="pubmed">37094222</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohlsson, C. et al. Low progesterone and low estradiol levels associate with abdominal aortic aneurysms in men. J. Clin. Endocrinol. Metab.107, dgab867 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8947245</ArticleId><ArticleId IdType="pubmed">34865072</ArticleId></ArticleIdList></Reference><Reference><Citation>Vermeulen, A. in The Endocrine Function of the Human Testis (eds James, V. H. T. et al.) 157&#x2013;170 (Academic, 1973).</Citation></Reference><Reference><Citation>Brodin, P., Duffy, D. &amp; Quintana-Murci, L. A call for blood&#x2014;in human immunology. Immunity50, 1335&#x2013;1336 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">31216453</ArticleId></ArticleIdList></Reference><Reference><Citation>Bray, N. L., Pimentel, H., Melsted, P. &amp; Pachter, L. Near-optimal probabilistic RNA-seq quantification. Nat. Biotechnol.34, 525&#x2013;527 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">27043002</ArticleId></ArticleIdList></Reference><Reference><Citation>Love, M. I., Huber, W. &amp; Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol.15, 550 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4302049</ArticleId><ArticleId IdType="pubmed">25516281</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu, G., Wang, L.-G., Han, Y. &amp; He, Q.-Y. clusterProfiler: an R package for comparing biological themes among gene clusters. Omics16, 284&#x2013;287 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3339379</ArticleId><ArticleId IdType="pubmed">22455463</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu, D., Milutinovic, M. D. &amp; Walt, D. R. Single molecule array (Simoa) assay with optimal antibody pairs for cytokine detection in human serum samples. Analyst140, 6277&#x2013;6282 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">26270328</ArticleId></ArticleIdList></Reference><Reference><Citation>Li, S. et al. Molecular signatures of antibody responses derived from a systems biology study of five human vaccines. Nat. Immunol.15, 195&#x2013;204 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3946932</ArticleId><ArticleId IdType="pubmed">24336226</ArticleId></ArticleIdList></Reference><Reference><Citation>Browaeys, R., Saelens, W. &amp; Saeys, Y. NicheNet: modeling intercellular communication by linking ligands to target genes. Nat. Methods17, 159&#x2013;162 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">31819264</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu, Z., Gu, L., Eils, R., Schlesner, M. &amp; Brors, B. circlize implements and enhances circular visualization in R. Bioinformatics30, 2811&#x2013;2812 (2014).</Citation><ArticleIdList><ArticleId IdType="pubmed">24930139</ArticleId></ArticleIdList></Reference><Reference><Citation>Satpathy, A. T. et al. Massively parallel single-cell chromatin landscapes of human immune cell development and intratumoral T cell exhaustion. Nat. Biotechnol.37, 925&#x2013;936 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7299161</ArticleId><ArticleId IdType="pubmed">31375813</ArticleId></ArticleIdList></Reference><Reference><Citation>Becht, E. et al. Dimensionality reduction for visualizing single-cell data using UMAP. Nat. Biotechnol.37, 38&#x2013;44 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">30531897</ArticleId></ArticleIdList></Reference><Reference><Citation>Mikes, J., Olin, A., Lakshmikanth, T., Chen, Y. &amp; Brodin, P. Mass cytometry, methods and protocols. Methods Mol Biol.1989, 111&#x2013;123 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">31077102</ArticleId></ArticleIdList></Reference><Reference><Citation>Gassen, S. V. et al. FlowSOM: using self&#x2010;organizing maps for visualization and interpretation of cytometry data. Cytometry A87, 636&#x2013;645 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">25573116</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolf, F. A. et al. PAGA: graph abstraction reconciles clustering with trajectory inference through a topology preserving map of single cells. Genome Biol.20, 59 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6425583</ArticleId><ArticleId IdType="pubmed">30890159</ArticleId></ArticleIdList></Reference><Reference><Citation>Lundberg, M., Eriksson, A., Tran, B., Assarsson, E. &amp; Fredriksson, S. Homogeneous antibody-based proximity extension assays provide sensitive and specific detection of low-abundant proteins in human blood. Nucleic Acids Res.39, e102&#x2013;e102 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3159481</ArticleId><ArticleId IdType="pubmed">21646338</ArticleId></ArticleIdList></Reference><Reference><Citation>Swerdloff, R. S., Dudley, R. E., Page, S. T., Wang, C. &amp; Salameh, W. A. Dihydrotestosterone: biochemistry, physiology, and clinical implications of elevated blood levels. Endocr. Rev.38, 220&#x2013;254 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6459338</ArticleId><ArticleId IdType="pubmed">28472278</ArticleId></ArticleIdList></Reference><Reference><Citation>Nathan, M. R. &amp; Schmid, P. A review of fulvestrant in breast cancer. Oncol. Ther.5, 17&#x2013;29 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5488136</ArticleId><ArticleId IdType="pubmed">28680952</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodero, M. P. et al. Detection of interferon alpha protein reveals differential levels and cellular sources in disease. J. Exp. Med.214, 1547&#x2013;1555 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5413335</ArticleId><ArticleId IdType="pubmed">28420733</ArticleId></ArticleIdList></Reference><Reference><Citation>Folin, R., Tadepally, L. &amp; Brodin, P. Gender-affirming-testosterone-treatment. 10.5281/zenodo.11517624 (2024).</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>